Blackstone Holdings I/II GP L.L.C. 13D and 13G filings for Galera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-04 4:32 pm Purchase | 2023-12-04 | 13D | Galera Therapeutics, Inc. GRTX | Blackstone Holdings I/II GP L.L.C. | 2,289,605 4.200% | 15,000 (+0.66%) | Filing |
| 2023-02-09 4:49 pm Purchase | 2021-07-19 | 13D | Galera Therapeutics, Inc. GRTX | Blackstone Holdings I/II GP L.L.C. | 2,274,605 7.800% | 568,197 (+33.30%) | Filing |
| 2022-02-11 06:11 am Purchase | 2021-12-31 | 13G | Galera Therapeutics, Inc. GRTX | Blackstone Holdings I/II GP L.L.C. | 1,706,408 6.400% | 19,184 (+1.14%) | Filing |
| 2021-02-16 5:01 pm Purchase | 2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX | Blackstone Holdings I/II GP L.L.C. | 1,687,224 6.800% | 1,687,224 (New Position) | Filing |